Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects.

Neureiter D, J├Ąger T, Ocker M, Kiesslich T.

World J Gastroenterol. 2014 Jun 28;20(24):7830-7848. Review.

PMID:
24976721
[PubMed - as supplied by publisher]
Free PMC Article
2.

Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells.

Shafaghati N, Hedayati M, Hosseinimehr SJ.

Pharmacogn Mag. 2014 Apr;10(38):106-10. doi: 10.4103/0973-1296.131020.

PMID:
24914274
[PubMed]
Free PMC Article
3.

Natural compounds as anticancer agents: Experimental evidence.

Wang J, Jiang YF.

World J Exp Med. 2012 Jun 20;2(3):45-57. doi: 10.5493/wjem.v2.i3.45. eCollection 2012 Jun 20. Review.

PMID:
24520533
[PubMed]
Free PMC Article
4.

pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).

Radhakrishnan VM, Kojs P, Young G, Ramalingam R, Jagadish B, Mash EA, Martinez JD, Ghishan FK, Kiela PR.

PLoS One. 2014 Jan 22;9(1):e85796. doi: 10.1371/journal.pone.0085796. eCollection 2014.

PMID:
24465712
[PubMed - in process]
Free PMC Article
5.

Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered.

Dahmke IN, Backes C, Rudzitis-Auth J, Laschke MW, Leidinger P, Menger MD, Meese E, Mahlknecht U.

PLoS One. 2013 Dec 12;8(12):e81122. doi: 10.1371/journal.pone.0081122. eCollection 2013.

PMID:
24349037
[PubMed - in process]
Free PMC Article
6.

Bioavailability of a lipidic formulation of curcumin in healthy human volunteers.

Pawar YB, Munjal B, Arora S, Karwa M, Kohli G, Paliwal JK, Bansal AK.

Pharmaceutics. 2012 Oct 9;4(4):517-30. doi: 10.3390/pharmaceutics4040517.

PMID:
24300368
[PubMed]
Free PMC Article
7.

Protein kinase C: an attractive target for cancer therapy.

Marengo B, De Ciucis C, Ricciarelli R, Pronzato MA, Marinari UM, Domenicotti C.

Cancers (Basel). 2011 Feb 1;3(1):531-67. doi: 10.3390/cancers3010531.

PMID:
24212628
[PubMed]
Free PMC Article
8.

Reversed-phase High-performance Liquid Chromatography Method for Analysis of Curcuminoids and Curcuminoid-loaded Liposome Formulation.

Jangle RD, Thorat BN.

Indian J Pharm Sci. 2013 Jan;75(1):60-6. doi: 10.4103/0250-474X.113555.

PMID:
23901162
[PubMed]
Free PMC Article
9.

Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.

Milano F, Mari L, van de Luijtgaarden W, Parikh K, Calpe S, Krishnadath KK.

Front Oncol. 2013 May 29;3:137. doi: 10.3389/fonc.2013.00137. eCollection 2013.

PMID:
23755374
[PubMed]
Free PMC Article
10.

Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.

Godwin P, Baird AM, Heavey S, Barr MP, O'Byrne KJ, Gately K.

Front Oncol. 2013 May 16;3:120. doi: 10.3389/fonc.2013.00120. eCollection 2013.

PMID:
23720710
[PubMed]
Free PMC Article
11.
12.

New perspectives of curcumin in cancer prevention.

Park W, Amin AR, Chen ZG, Shin DM.

Cancer Prev Res (Phila). 2013 May;6(5):387-400. doi: 10.1158/1940-6207.CAPR-12-0410. Epub 2013 Mar 6. Review.

PMID:
23466484
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.

Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, He S, Mo X, Chiu M, Wang QE, He X, Liu S, Grever MR, Chan KK, Liu Z.

PLoS One. 2013;8(2):e55934. doi: 10.1371/journal.pone.0055934. Epub 2013 Feb 13.

PMID:
23457487
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Oxidative metabolites of curcumin poison human type II topoisomerases.

Ketron AC, Gordon ON, Schneider C, Osheroff N.

Biochemistry. 2013 Jan 8;52(1):221-7. doi: 10.1021/bi3014455. Epub 2012 Dec 26.

PMID:
23253398
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2013 Feb;42(2):741-8. doi: 10.3892/ijo.2012.1734. Epub 2012 Dec 12.

PMID:
23232667
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction.

Pan J, Li H, Ma JF, Tan YY, Xiao Q, Ding JQ, Chen SD.

Transl Neurodegener. 2012 Aug 20;1(1):16. doi: 10.1186/2047-9158-1-16.

PMID:
23210631
[PubMed]
Free PMC Article
17.

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.

Gandhy SU, Kim K, Larsen L, Rosengren RJ, Safe S.

BMC Cancer. 2012 Nov 30;12:564. doi: 10.1186/1471-2407-12-564.

PMID:
23194063
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Therapeutic roles of curcumin: lessons learned from clinical trials.

Gupta SC, Patchva S, Aggarwal BB.

AAPS J. 2013 Jan;15(1):195-218. doi: 10.1208/s12248-012-9432-8. Epub 2012 Nov 10. Review.

PMID:
23143785
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Chemoprevention of prostate cancer: soy isoflavones and curcumin.

Horie S.

Korean J Urol. 2012 Oct;53(10):665-72. doi: 10.4111/kju.2012.53.10.665. Epub 2012 Oct 19.

PMID:
23136625
[PubMed]
Free PMC Article
20.

Pancreatic cancer chemoprevention by phytochemicals.

Boreddy SR, Srivastava SK.

Cancer Lett. 2012 Oct 27. pii: S0304-3835(12)00625-8. doi: 10.1016/j.canlet.2012.10.020. [Epub ahead of print]

PMID:
23111102
[PubMed - as supplied by publisher]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk